BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden

Behavioral and Psychological Symptoms of Dementia (BPSD) are a heterogeneous set of psychological and behavioral abnormalities seen in persons with dementia (PwD), significantly impacting their quality of life and that of their caregivers. Current assessment tools, such as the Neuropsychiatric Inventory (NPI), are limited by recall bias and lack of direct observation. This study aims to overcome this limitation by making caregiver reports more objective through the use of a novel instrument, referred to as the BPSDiary. This randomized controlled trial will involve 300 caregiver-PwD dyads. The objective is to evaluate whether the use of the BPSDiary could significantly reduce caregiver burden, assessed using the Zarit Burden Interview (ZBI), compared to usual care. The study will include adult PwD, caregivers living with or close to the patient, and BPSD related to the HIDA (hyperactivity, impulsivity, irritability, disinhibition, aggression, agitation) domain. Caregivers randomized to the intervention arm will use the BPSDiary to record specific BPSD, including insomnia, agitation/anxiety, aggression, purposeless motor behavior, and delusions/hallucinations, registering time of onset, severity, and potential triggers. The primary outcome will be the change in ZBI scores at 3 months, with secondary outcomes including changes in NPI scores, olanzapine equivalents, NPI-distress scores related to specific BPSD domains, and caregiver and physician satisfaction. The study will be conducted in 9 Italian centers, representing diverse geographic and sociocultural contexts. While potential limitations include the relatively short observation period and the focus on specific BPSD disturbances, the BPSDiary could provide physicians with objective data to tailor appropriate non-pharmacological and pharmacological interventions. Additionally, it may empower caregivers by encouraging reflection on BPSD triggers, with the potential to improve the quality of life for both PwD and their caregivers.

Trial registry: NCT05977855.

1 Introduction

The behavioral and psychological symptoms of dementia (BPSD) are a heterogeneous set of psychological reactions, psychiatric symptoms, and behavioral abnormalities that are present in persons with dementia (PwD) due to any etiology (D'antonio et al., 2022). These have been grouped in different clusters across different studies. One of the most common classifications divides them into five clusters: psychosis (delusions and hallucinations), affective symptoms (anxiety and depression), apathy, psychomotor symptoms (irritability, aberrant motor behaviors, agitation), and mania (euphoria and disinhibition). In Italy, the most common BPSD seem to be agitation, apathy, depression, psychosis, and aggression (D'antonio et al., 2022). It is likely that cultural and ethnic differences might partially explain the heterogeneity and relevance of BPSD across different countries and settings, as well as caregivers' responses (Abe et al., 2015).

BPSD are extremely relevant for PwD, as they are associated with a faster cognitive decline, loss of independence, falls, and institutionalization (Calsolaro et al., 2021). BPSD might be present across all stages of dementia, and even predate it (in the so-called mild behavioral impairment, MBI) (Ismail et al., 2017). Specific BPSD, such as apathy, might also predict conversion from mild cognitive impairment to dementia (Fresnais et al., 2022).

Several instruments have been proposed to assess BPSD. More than sixty scales and tools have been developed, the most commonly used probably being the Neuropsychiatric Inventory (NPI); however, none of them seems to satisfactorily address all relevant aspects of BPSD (Pozzi et al., 2023). Most instruments are limited by the high degree of recall bias, lack of direct observation, and length (D'antonio et al., 2022). Finally, an intrinsic risk using broad tools such as the NPI is the imprecise evaluation of BPSD as a unitary construct, aggregating symptoms with different biological basis and treatments (Cho et al., 2021).

Several modifiable and non-modifiable risk factors for BPSD have been identified in the literature. Inconclusive results have been published for APOE4, while polymorphisms in other genes, such as COMT, serotonin receptor 2A and IL-1β seem to correlate with specific BPSD (Flirski et al., 2011). Other non-modifiable “background factors” might be low education and female gender (Chang et al., 2020). On the contrary, “proximal factors,” which are temporally close to BPSD, might be potentially modifiable, and mostly include triggers and relational aspects between PwD and their caregivers (Cho et al., 2021; Nagata et al., 2022).

Current guidelines suggest to address proximal factors with non-pharmacological strategies as a first line treatment (Calsolaro et al., 2021). In practice, psychotropic medication are still largely used, possibly with the exception of BPSD pertaining to eating and sleeping (D'antonio et al., 2022). However, antipsychotics have several side effects (D'antonio et al., 2022), and despite FDA and European Medicine Agency black-box warnings they are often used for long periods, with an increasing risk of parkinsonism, sedation, falls, stroke, cognitive decline and death (Calsolaro et al., 2021). Nevertheless, the use of antipsychotics, acetylcholinesterase inhibitors and memantine seems to be associated with a reduced caregiver burden (Levy et al., 2012).

Non-pharmacological algorithms include DICE (Describe, Investigate, Create, Evaluate) (Kales et al., 2019) and DATE (Describe & Measure, Analyze, Treat, Evaluate) (Cho et al., 2021). Both rely on precise characterization of triggers to find optimal solution to address BPSD. Functional analysis is generally based on ABC approach, evaluating antecedent (trigger), behavior description and consequence. A meta-analysis demonstrated that functional analysis with tailored strategies for PwD and caregivers positively impact burdensome BPSD frequency and caregivers' reaction, but has no effect on incidence or severity of BPSD, mood or caregiver burden (Moniz Cook et al., 2008). In Italy, caregiver education is the most common non-pharmacological intervention, used by 86% of caregivers as a fist line (D'antonio et al., 2022).

An unmet need for physicians is the availably of more objective tools for severity, frequency and context of BPSD, in order to apply non-pharmacological strategies (Loi and Lautenschlager, 2017). In Italy, 93% of physicians working in the field of dementia would be interested in a new tool to address BPSD, which reflects the unsatisfactory nature of current options (D'antonio et al., 2022).

Among BPSD, those belonging to the HIDA domain (hyperactivity, impulsivity, irritability, disinhibition, aggression, agitation) seem to be the most difficult to treat (Van der Linde et al., 2014; Keszycki et al., 2019). Person-centered strategies, including positive and significant social interactions, reminiscence therapy among others, seem to have a beneficial effect, albeit modest (Keszycki et al., 2019). A recent study evaluated caregiver burden and BPSD assessment with daily phone interviews over the course of eight days, showing that the quality of the relationship between caregivers and PwD attenuates caregivers stress related to BPSD (Chunga et al., 2021). Several instruments exist to evaluate caregiver burden, the most common being the Zarit Burden Interview (ZBI) (Melo et al., 2011; Liu et al., 2017; Griffiths et al., 2018; Evans et al., 2021; Jhang et al., 2021; Kanemoto et al., 2021), whose Italian version has been validated and is freely available (Chattat et al., 2011). The ZBI includes 22 questions, each scored with a 0–4 Likert scale, with a total score above 25 indicating a clinically significant burden. Generally speaking, the most burdensome BPSD include delusions, aggression, aberrant motor behavior, agitation and irritability, which substantially overlap with the HIDA domain (Fauth and Gibbons, 2014; Hiyoshi-Taniguchi et al., 2018).

A rather neglected field is satisfaction of caregivers for care provided by physicians to PwD. No instrument for healthcare satisfaction has been validated in caregivers of PwD, or in BPSD, and many instruments seem excessively long.¹ On the other hand, there is a lack of instruments evaluating physicians satisfaction in treating PwD.

The main idea of our study is to make caregiver's evaluation of BPSD more objective, partially eliminating recall bias through the use of a daily diary focusing on the most disturbing BPSD and their triggers. This would also overcome the limitation of the observation by the physician, which is limited to the short period of the visits and may not capture relevant phenomena present at home. A diary has already been used in another recent study, with a checklist based on NPI in one case (Cho et al., 2021), and a rather long checklist of 53 behaviors in another one (Fauth et al., 2006). However, none of these approaches was treatment-oriented, and triggers were not evaluated. Therefore, we expect that our instrument, called “BPSDiary,” would allow a more precise and treatment-oriented assessment of BPSD, providing physicians with relevant data to implement non-pharmacological and tailored strategies to address them and eventually reduce caregivers' burden.

2 Methods and analysis

Based on the premises mentioned above, we present here the protocol for a non-pharmacological parallel-arm randomized controlled trial named “Use of a Diary to Assess and Monitor Behavioral and Psychological Symptoms of Dementia.” The study will randomize 300 dyads (persons with dementia and their caregivers) to either the use of the BPSDiary to record BPSD or usual care. In this context, usual care means the way involved physicians usually treat their patients, according to existing guidelines, personal experience, or both. The main objective is to evaluate whether the use of the BPSDiary can lead to a significant reduction of ZBI scores at 3 months compared to usual care.

Inclusion criteria will be as follows:

- Adult patients with cognitive impairment (either MCI or dementia, either neurodegenerative or vascular or both, diagnosed by a physician with experience in dementia care)

- Willingness of both caregiver and patient to take part in the study

- Caregiver living with the patient, or able to cover the whole day (e.g., caregiver living in the same building)

- Presence of BPSD pertaining to the HIDA domain, as inferred by the physician during the screening visit

- Signed informed consent from both patient and caregiver, as requested by the ethical committee

Dyads will be excluded if they do not provide written consent to participate in the study.

The study will be conducted across the Centers for Dementia and Cognitive Decline of nine Italian centers, distributed along the peninsula. These centers have been selected based on their regional importance and expertise in managing BPSD. Sixty patients will be recruited at the Fondazione IRCCS San Gerardo dei Tintori (Monza, Lombardy), while 30 patients each will be enrolled in the remaining centers. These will include the following eight centers: Fondazione IRCCS Don Gnocchi (Milan, Italy), IRCCS Fondazione Mondino (Pavia, Italy), Ospedale Multimedica (Castellanza, Lombardy), AO Padova (Padova, Veneto), AOU Careggi (Florence, Tuscany), Sapienza University (Rome, Lazio), Ospedale SS Annunziata (Chieti, Abruzzo), Pia Fondazione Cardinale Panico (Bari, Apulia). The geographical distribution of the involved centers is shown in Figure 1.

FIGURE 1

Figure 1. Geographical distribution of involved centers. From North to South: Castellanza (west), Monza (east), Milan, Pavia, Padua (east), Florence, Chieti, Rome, Bari.

The dyads will be randomized in a 1:1 allocation ratio with a process of covariate adaptive randomization (Suresh, 2011), using caregiver age (cut-off 60 years old; this cut-off is chosen to ensure an equal representation of young/middle-age and elderly caregivers), patient comorbidity [Cumulative Illness Rating Scale (CIRS) – comorbidity index (Salvi et al., 2008) cut-off of 1], patient gender, patient functional independence [Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) preserved vs. either of them not preserved] and baseline ZBI (cut-off of 31 points). Randomization will be performed through a dedicated software, as previously shown by other groups (O'Callaghan, 2014; Guillaumes and O'Callaghan, 2019).

At baseline, the following scales will be administered to the dyads: CIRS, ADL, IADL, NPI, ZBI, MMSE. These scales will be administered in a quiet environment, free of distractions. Data will also be gathered on age, gender, education of both caregivers and patients, and drugs used by the patients.

The caregivers randomized to the intervention arm will be instructed to use the BPSDiary to register specific behaviors of interest (the BPSDiary is available in the Supplementary material). These include insomnia, agitation/anxiety, aggression (either physical or verbal), purposeless motor behavior, delusions/hallucinations. The caregiver will have to mark any occurrence of these BPSD by indicating the time of onset, ticking the appropriate severity box (mild or severe) and writing down possible triggers. An introductory page explains the definitions of each term in plain language and provides examples. The data in the diary are then transposed on an interactive excel file (available at https://drive.google.com/file/d/1i3_NY7MRg9uoe2kD5njkUhax1zS9engp/view?usp=sharing) that allows the treating physician to analyze several aspects of the BPSD of the patient, such as their temporal pattern, severity, prevalence and triggers. The BPSDiary is only offered in a “paper and pencil” version, to avoid issues related with poor digital skills of elderly caregivers in Italy.

After the first 6 weeks the caregiver will be contacted by telephone and he/she will be asked if there are any issues related to BPSD. Caregivers randomized to the intervention arm will be asked to send the first six pages of the diary for analysis. Appropriate actions will be taken to address any issue according to the treating physician's judgment; options may include telephone counseling, scheduling a visit, prescribing or deprescribing drugs and so on. All of this will be repeated after other 6 weeks. All the approaches will be recorded and accounted for in the analyses.

The following scales will be re-administered at the end of the study (3 months): NPI, ZBI, and the satisfaction questionnaires (available in the Supplementary material). The other scales (ADL, IADL, MMSE) will not be administered, as they are judged unlikely to significantly change in the study period, and even if they do, this would probably not be related to the use of the diary.

The caregiver will be allowed to contact the treating physician at any time during the entirety of the study in case urgent actions need to be taken to address BPSD; dyads randomized to the diary will be asked to send it to the doctor for analysis. Actions taken during these unscheduled contacts will be registered in the following scheduled contact window (e.g., if the contact takes place at week 4 and quetiapine is introduced, this will be registered at the first of the two scheduled contacts at week 6).

The primary outcome will be the variation on the ZBI at 3 months. Secondary outcomes will include variation on NPI, olanzapine equivalents [calculated with the Defined Daily Doses method (Leucht et al., 2016)], caregiver care-related satisfaction, and variation on relevant NPI-distress scores at 3 months, as well as caregiver and physician diary-related satisfaction. Relevant NPI-distress scores include scores related to insomnia, agitation, aberrant motor behavior, aggression, delusions, hallucinations (i.e., the domains assessed in the BPSDiary).

The entire study will last 13 months. Enrollment will take place over the course of 9 months, and each dyad will be followed for 12 weeks. Data analysis is expected to take another month.

Sample size has been computed with the software gpower (Erdfelder et al., 2009) considering a clinically significant difference of at least 6 points at the ZBI, corresponding to an effect size of 0.428 with a t-test. Considering α = 0.05 and β = 0.05, 238 would be required. We hypothesized a drop-out rate of 20%, based on clinical experience on similar studies; therefore, 300 dyads are required. The power graph is shown in Figure 2.

FIGURE 2

Figure 2. Power graph for sample size calculation.

A t-test will be used to compare differences in ZBI variations (ZBI_followup-ZBI_baseline) between the two arms. A t-test will be also used to compare differences between the two arms in NPI, NPI-distress, olanzapine equivalents variations, as well as satisfaction questionnaires scores. Pre-specified analyses will include linear mixed effect models to compare ZBI trajectories, including arm, person's and caregiver's age, baseline MMSE, person's and caregiver's education, and olanzapine equivalents as possible predictors.

The registration data set is reported in Table 1. The CONSORT checklist (Schulz et al., 2010) for this RCT is available in the Supplementary material.

TABLE 1

Table 1. Registration data set.

3 Discussion

Several guidelines suggest the use of non-pharmacological interventions as a first line in the treatment of BPSD. However, the use of antipsychotics and other psychoactive medications is still common in Italy (Azermai et al., 2013), and this might be dependent on the fact that addressing triggers of disruptive behaviors is hard and heavily influenced by recall bias. Moreover, it seems that caregivers perceive systemic barriers in non-pharmacological interventions which are partially dependent on the inability of physicians to provide information, support, and coaching about such strategies (Kerns et al., 2018). On the contrary, caregivers might have the wrong idea that psychotropic medications are generally safe and effective, as they may not be aware of FDA black-box warnings on antipsychotics (Kerns et al., 2018). The use of the BPSDiary could theoretically allow for the identification of such triggers, which would help the clinician finding tailored non-pharmacological solutions for the management of BPSD. Moreover, it could allow caregivers to reflect on the mechanisms and causes of behaviors, which might give them a sense of empowerment.

A strength of our protocol is the representation of almost all Italian peninsula. Thanks to the variety of customs and societal characteristics in different Italian regions, the inclusion of centers representative of Northern, Central, and Southern Italy, as well as serving both Italian biggest cities (such as Rome and Milan) and smaller realities (such as Castellanza) will allow exploring the use of the diary in diverse settings, drawing considerations about its reception, adaptability, and implementation. This is important, as several disparities among Italian regions and contexts, such as living conditions, education, and social isolation, which are associated with varying levels of reported health (Franzini and Giannoni, 2010), may also influence the assessment and management of BPSD. Another strength is the large anticipated sample size, that will incidentally allow exploring secondary outcomes, as well as analyzing the effect of different variables such as specific dementia type to evaluate which kind of patient might benefit the most from the intervention.

We acknowledge that the inclusion of people with MCI might be controversial. On one hand, MCI people are usually not expected to be cared for by a caregiver, as their level of cognitive impairment should not significantly impact their daily activities by definition. On the other hand, we cannot exclude the fact that a caregiver might be indeed present for elderly people even when their cognitive impairment is still mild, especially when there are other comorbidities. Perhaps inherently to Italian society, it is still common to provide “care” for elderly relatives even when there is no loss of autonomy. Moreover, certain behavioral abnormalities might be indeed present in the early phases of certain neurodegenerative conditions such as DLB even in the “MCI” phase. For instance, the presence of hallucinations is a core feature of the 2020 McKeith's criteria of MCI-LB (McKeith et al., 2020). In other cases, MCI might be associated with a condition called mild behavioral impairment, which may increase the likelihood of progression of the cognitive impairment (Mallo et al., 2018; Ruthirakuhan et al., 2022).

A foreseeable limitation is the relatively short period of observation. However, this is comparable with the observation period used in other tools we used to evaluate concurrent validity, such as the NPI (Kaufer et al., 1998; Pozzi et al., 2023). Moreover, the inclusion criteria imply the presence of BPSD relative to the HIDA domain, which are associated with worse outcomes in PwD. Therefore, longer periods of observation could in theory increase the drop-out rate and therefore require an even larger sample size. A period of 3 months was judged to be a good compromise between all these considerations.

Another potential weakness is the decision to restrict BPSD assessment to only a certain subset of symptoms. Broad BPSD assessment tools that evaluate all possible disturbances already exist (Kales et al., 2017, 2018), but our intention was to target specifically those symptoms that greatly affect caregivers and result in worse outcomes for the PwD (Fauth and Gibbons, 2014; Hiyoshi-Taniguchi et al., 2018). On one hand, this will ensure that our tool is easy to use and understand, requiring caregivers to detect only the most striking behaviors, and also fast to complete, requiring only a minimum set of information to be provided. The decision to distinguish only two categories of severity (“mild” and “severe”) is in line with the perceived difficulty of caregiver to assign numbers to quantify behavior. As people of science, we tend to believe that numbers mean everything, but most of caregivers do not categorize their experiences mathematically, and forcing them to do so may result in some extent of arbitrariness that might jeopardize the assessment. We believe that our diary represents a good compromise between the two opposite tendencies of scientists and healthcare users, asking them to provide easy categories for analysis, but at the same time allowing them to reflect on and express freely their understanding of the triggers of BPSD of the PwD that they care for. While we did not conduct a proper feasibility study, during the preparation for the trial we proposed the instrument to 20 dyads at the Fondazione IRCCS San Gerardo and asked them about their opinions (qualitative data not shown). As expected, caregivers who were not cohabitating with patients reported greater difficulty in completing the diary, which led us to require cohabitation or ability to cover the whole day among inclusion criteria.

Finally, it could be argued that a “paper and pencil” diary could be somehow anachronistic in our hyper-digitalized society. However, our choice was mainly motivated by the fact that most of the caregiver that we expect to recruit will be quite old (i.e., spouses of enrolled PwD). While the creation of apps for senior citizens requires particular care regarding usability issues (Tajudeen et al., 2022), it is also possible that even a perfect app could fail in theory, due to specific country-related issues. Indeed, elderly Italian seem to have restricted digital skills compared to other countries (Caliandro et al., 2021; Melchior, 2023; Vainieri et al., 2023; Valokivi et al., 2023), which could represent a foreseeable barrier for the implementation of a study with an app. Therefore, we expect the paper version of the diary to be more acceptable by the majority of enrolled caregivers. Nevertheless, if the study will show promising results, it is our intention to try and develop an app version, possibly targeting younger caregivers.

Ethics statement

The study was approved by the Ethical Committee “Comitato Etico Brianza,” with approval number 4251, on May 15^th, 2023. Recruitment strategies will use different channels. First, the study will be proposed to PwD and caregiver meeting inclusion criteria and already attending the involved memory clinics. Secondly, the study will be advertised on the websites of the involved centers. Lastly, depending on local availability, the study could be advertised to a broader audience through coverage by local media (e.g., newspaper articles).

Author contributions

FP: Conceptualization, Writing—original draft, Writing—review & editing. LC: Writing—review & editing. FD'A: Writing— review & editing. AA: Writing—review & editing. MS: Writing—review & editing. MP: Writing—review & editing. AD: Writing—review & editing. RP: Writing—review & editing. LB: Writing—review & editing. VC: Writing—review & editing. CB: Writing—review & editing. ACa: Writing—review & editing. DU: Writing—review & editing. DV: Writing—review & editing. GL: Writing—review & editing. MA: Writing—review & editing. BA: Writing—review & editing. EF: Writing—review & editing. FR: Writing—review & editing. AG: Writing—review & editing. MZ: Writing—review & editing. GB: Writing—review & editing. VB: Writing—review & editing. MC: Writing—review & editing. GP: Writing—review & editing. ACo: Writing—review & editing. CF: Writing—review & editing. IA: Writing—review & editing. LT: Writing—review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This publication was produced with the co-funding European Union -Next Generation EU, in the context of The National Recovery and Resilience Plan, Investment Partenariato Esteso PE8 Conseguenze e sfide dell'invecchiamento, Project Age-It (Aging Well in an Aging Society). Italian MUR Dipartimenti di Eccellenza 2023-2027 (l. 232/2016, art. 1, commi 314 -337).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/frdem.2023.1301280/full#supplementary-material

Footnotes

1. ^http://www.psychiatryonline.it/node/3704

References

Abe, K., Yamashita, T., Hishikawa, N., Ohta, Y., Deguchi, K., Sato, K., et al. (2015). A new simple score (ABS) for assessing behavioral and psychological symptoms of dementia. J. Neurol. Sci. 350, 14–17. doi: 10.1016/j.jns.2015.01.029

PubMed Abstract | CrossRef Full Text | Google Scholar

Azermai, M., Kane, J., Liperoti, R., Tsolaki, M., Landi, F., Passmore, A. P., et al. (2013). Management of behavioural and psychological symptoms of dementia: Belgium, Greece, Italy, United Kingdom. Eur. Geriatr. Med. 4, 50–58. doi: 10.1016/j.eurger.2012.06.008

CrossRef Full Text | Google Scholar

Caliandro, A., Garavaglia, E., Sturiale, V., and Di Leva, A. (2021). Older people and smartphone practices in everyday life: an inquire on digital sociality of italian older users. Commun. Rev. 24, 47–78. doi: 10.1080/10714421.2021.1904771

CrossRef Full Text | Google Scholar

Calsolaro, V., Femminella, G. D., Rogani, S., Esposito, S., Franchi, R., Okoye, C., et al. (2021). Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics. Pharmaceuticals. 14:246. doi: 10.3390/ph14030246

PubMed Abstract | CrossRef Full Text | Google Scholar

Chang, K. H., Huang, C. C., Chen, C. M., Wu, H. C., and Kuo, H. C. (2020). Differences in clinical presentation of behavioral and psychological symptoms of dementia in Alzheimer's disease according to sex and education level. J. Alzheimer's Dis. 78, 711–719. doi: 10.3233/JAD-200507

PubMed Abstract | CrossRef Full Text | Google Scholar

Chattat, R., Cortesi, V., Izzicupo, F., Del Re, M. L., Sgarbi, C., Fabbo, A., et al. (2011). The Italian version of the Zarit Burden Interview: a validation study. Int. Psychogeriatrics. 23, 797–805. doi: 10.1017/S1041610210002218

PubMed Abstract | CrossRef Full Text | Google Scholar

Cho, E., Kim, S., Hwang, S., Kwon, E., Heo, S. J., Lee, J. H., et al. (2021). Factors associated with behavioral and psychological symptoms of dementia: prospective observational study using actigraphy. J. Med. Internet Res. 23:e29001. doi: 10.2196/29001

PubMed Abstract | CrossRef Full Text | Google Scholar

Chunga, R. E., Kim, K., Liu, Y., and Zarit, S. H. (2021). Family caregivers' distress responses to daily behavioral and psychological symptoms of dementia: the moderating role of relationship quality. Int. J. Geriatr. Psychiatry. 36, 822–830. doi: 10.1002/gps.5482

PubMed Abstract | CrossRef Full Text | Google Scholar

D'antonio, F., Tremolizzo, L., Zuffi, M., Pomati, S., Farina, E., Bpsd, S., et al. (2022). Clinical perception and treatment options for behavioral and psychological symptoms of dementia (BPSD) in Italy. Front. Psychiatry. 1:843088. doi: 10.3389/fpsyt.2022.843088

PubMed Abstract | CrossRef Full Text | Google Scholar

Erdfelder, E., FAul, F., Buchner, A., and Lang, A. G. (2009). Statistical power analyses using G^*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods 41, 1149–1160. doi: 10.3758/BRM.41.4.1149

PubMed Abstract | CrossRef Full Text | Google Scholar

Evans, T. L., Kunik, M. E., Snow, A. L., Shrestha, S., Richey, S., Ramsey, D. J., et al. (2021). Validation of a brief screen to identify persons with dementia at risk for behavioral problems. J. Appl. Gerontol. 40, 1587–1595. doi: 10.1177/0733464821996521

PubMed Abstract | CrossRef Full Text | Google Scholar

Fauth, E. B., and Gibbons, A. (2014). Which behavioral and psychological symptoms of dementia are the most problematic? variability by prevalence, intensity, distress ratings, and associations with caregiver depressive symptoms. Int. J. Geriatr. Psychiatry. 29, 263–271. doi: 10.1002/gps.4002

PubMed Abstract | CrossRef Full Text | Google Scholar

Fauth, E. B., Zarit, S. H., Femia, E. E., Hofer, S. M., and Stephens, M. A. P. (2006). Behavioral and psychological symptoms of dementia and caregivers' stress appraisals: intra-individual stability and change over short-term observations. Aging Ment. Health 10, 563–573. doi: 10.1080/13607860600638107

PubMed Abstract | CrossRef Full Text | Google Scholar

Flirski, M., Sobow, T., and Kloszewska, I. (2011). Behavioural genetics of Alzheimer's disease: a comprehensive review. Arch. Med. Sci. 7, 195–210. doi: 10.5114/aoms.2011.22068

CrossRef Full Text | Google Scholar

Franzini, L., and Giannoni, M. (2010). Determinants of health disparities between Italian regions. BMC Public Health 10:296. doi: 10.1186/1471-2458-10-296

PubMed Abstract | CrossRef Full Text | Google Scholar

Fresnais, D., Humble, M. B., Bejerot, S., Meehan, A. D., and Fure, B. (2022). Apathy as a predictor for conversion from mild cognitive impairment to dementia: a systematic review and meta-analysis of longitudinal studies. J. Geriatr. Psychiatry Neurol. 36, 3–17. doi: 10.1177/08919887221093361

PubMed Abstract | CrossRef Full Text | Google Scholar

Griffiths, P. C., Kovaleva, M., Higgins, M., Langston, A. H., and Hepburn, K. (2018). Tele-savvy: an online program for dementia caregivers. Am. J. Alzheimers Dis. Other Demen. 33, 269–276. doi: 10.1177/1533317518755331

PubMed Abstract | CrossRef Full Text | Google Scholar

Guillaumes, S., and O'Callaghan, C. A. (2019). Spanish adaptation of the free OxMaR software for minimization and randomization of clinical studies. Gac. Sanit. 33, 395–397. doi: 10.1016/j.gaceta.2018.07.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Hiyoshi-Taniguchi, K., Becker, C. B., and Kinoshita, A. (2018). What behavioral and psychological symptoms of dementia affect caregiver burnout? Clin. Gerontol. 41, 249–254. doi: 10.1080/07317115.2017.1398797

PubMed Abstract | CrossRef Full Text | Google Scholar

Ismail, Z., Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., et al. (2017). The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. J. Alzheimer's Dis. 56, 929–938. doi: 10.3233/JAD-160979

CrossRef Full Text | Google Scholar

Jhang, K. M., Wang, W. F., Chang, H. F., Chang, M. C., and Wu, H. H. (2021). Characteristics predicting a high caregiver burden in patients with vascular cognitive impairment: using the apriori algorithm to delineate the caring scenario. Risk Manag. Healthc Policy 14, 1335–1351. doi: 10.2147/RMHP.S297204

PubMed Abstract | CrossRef Full Text | Google Scholar

Kales, H. C., Gitlin, L. N., and Lyketsos, C. G. (2019). When less is more, but still not enough: why focusing on limiting antipsychotics in people with dementia is the wrong policy imperative. J. Am. Med. Dir. Assoc. 20, 1074–1079. doi: 10.1016/j.jamda.2019.05.022

PubMed Abstract | CrossRef Full Text | Google Scholar

Kales, H. C., Gitlin, L. N., Stanislawski, B., Marx, K., Turnwald, M., Watkins, D. C., et al. (2017). WeCareAdvisor^TM: the development of a caregiver-focused, web-based program to assess and manage behavioral and psychological symptoms of dementia. Alzheimer Dis. Assoc. Disord. 31, 263–270. doi: 10.1097/WAD.0000000000000177

PubMed Abstract | CrossRef Full Text | Google Scholar

Kales, H. C., Gitlin, L. N., Stanislawski, B., Myra Kim, H., Marx, K., Turnwald, M., et al. (2018). Effect of the WeCareAdvisor^TM on family caregiver outcomes in dementia: a pilot randomized controlled trial. BMC Geriatr. 18, 1–12. doi: 10.1186/s12877-018-0801-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Kanemoto, H., Sato, S., Satake, Y., Koizumi, F., Taomoto, D., Kanda, A., et al. (2021). Impact of behavioral and psychological symptoms on caregiver burden in patients with dementia with lewy bodies. Front. Psychiatry. 12:753864. doi: 10.3389/fpsyt.2021.753864

PubMed Abstract | CrossRef Full Text | Google Scholar

Kaufer, D. I., Cummings, J. L., Christine, D., Bray, T., Castellon, S., Masterman, D., et al. (1998). Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the neuropsychiatric inventory caregiver distress scale. J. Am. Geriatr. Soc. 46, 210–215. doi: 10.1111/j.1532-5415.1998.tb02542.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Kerns, J. W., Winter, J. D., Winter, K. M., Kerns, C. C., and Etz, R. S. (2018). Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia. Gerontologist 58, e35–45. doi: 10.1093/geront/gnx042

PubMed Abstract | CrossRef Full Text | Google Scholar

Keszycki, R. M., Fisher, D. W., and Dong, H. (2019). The hyperactivity-impulsivity-irritiability-disinhibition-aggression-agitation domain in Alzheimer's disease: current management and future directions. Front. Pharmacol. 10:1109. doi: 10.3389/fphar.2019.01109

PubMed Abstract | CrossRef Full Text | Google Scholar

Leucht, S., Samara, M., Heres, S., and Davis, J. M. (2016). Dose equivalents for antipsychotic drugs: the DDD method. Schizophr. Bull. 42, S90–S94. doi: 10.1093/schbul/sbv167

PubMed Abstract | CrossRef Full Text | Google Scholar

Levy, K., Lanctôt, K. L., Farber, S. B., Li, A., and Herrmann, N. (2012). Does pharmacological treatment of neuropsychiatric symptoms in Alzheimers disease relieve caregiver burden? Drugs Aging 29, 167–179. doi: 10.2165/11599140-000000000-00000

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, S., Jin, Y., Shi, Z., Huo, Y. R., Guan, Y., Liu, M., et al. (2017). The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China. Aging Ment. Health 21, 651–657. doi: 10.1080/13607863.2016.1146871

PubMed Abstract | CrossRef Full Text | Google Scholar

Loi, S. M., and Lautenschlager, N. T. (2017). Investigating the current methods of assessing behavioral and psychological symptoms in residential aged care facilities in a metropolitan city. Int. Psychogeriatrics. 29, 855–858. doi: 10.1017/S104161021600226X

PubMed Abstract | CrossRef Full Text | Google Scholar

Mallo, S. C., Ismail, Z., Pereiro, A. X., Facal, D., Lojo-Seoane, C., Campos-Magdaleno, M., et al. (2018). Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment. J. Alzheimers Dis. 66, 83–95. doi: 10.3233/JAD-180131

CrossRef Full Text | Google Scholar

McKeith, I. G., Ferman, T. J., Thomas, A. J., Blanc, F., Boeve, B. F., Fujishiro, H., et al. (2020). Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 94, 743–755. doi: 10.1212/WNL.0000000000009323

PubMed Abstract | CrossRef Full Text | Google Scholar

Melchior, C. (2023). Elderly people and the barriers to digital education. Italian J. Sociol. Educ.15, 37–53. doi: 10.14658/PUPJ-IJSE-2023-2-3

CrossRef Full Text | Google Scholar

Melo, G., Maroco, J., and de Mendonça, A. (2011). Influence of personality on caregiver's burden, depression and distress related to the BPSD. Int. J. Geriatr. Psychiatry. 26, 1275–1282. doi: 10.1002/gps.2677

PubMed Abstract | CrossRef Full Text | Google Scholar

Moniz Cook, E. D., De Vugt, M., Verhey, F., and James, I. (2008). Functional analysis-based interventions for challenging behaviour in dementia. Cochrane Database Syst. Rev. 15:CD006929. doi: 10.1002/14651858.CD006929

PubMed Abstract | CrossRef Full Text | Google Scholar

Nagata, T., Shinagawa, S., Inamura, K., and Shigeta, M. (2022). Pathogenesis and personalized interventions for pharmacological treatment-resistant neuropsychiatric symptoms in Alzheimer's disease. J. Pers. Med. 12:1365. doi: 10.3390/jpm12091365

PubMed Abstract | CrossRef Full Text | Google Scholar

O'Callaghan, C. A. (2014). OxMaR: OPen source free software for online minimization and randomization for clinical trials. PLoS ONE 9:e0110761. doi: 10.1371/journal.pone.0110761

PubMed Abstract | CrossRef Full Text | Google Scholar

Pozzi, F. E., Cal,ì, L., Ferrarese, C., Appollonio, I., and Tremolizzo, L. (2023). Assessing behavioral and psychological symptoms of dementia: a comprehensive review of current options and future perspectives. Front. Dement. 2:1226060. doi: 10.3389/frdem.2023.1226060

CrossRef Full Text | Google Scholar

Ruthirakuhan, M., Ismail, Z., Herrmann, N., Gallagher, D., and Lanctôt, K. L. (2022). Mild behavioral impairment is associated with progression to Alzheimer's disease: a clinicopathological study. Alzheimer's Dement. 18, 2199–2208. doi: 10.1002/alz.12519

PubMed Abstract | CrossRef Full Text | Google Scholar

Salvi, F., Miller, M. D., Grilli, A., Giorgi, R., Towers, A. L., Morichi, V., et al. (2008). A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J. Am. Geriatr. Soc. 56, 1926–1931. doi: 10.1111/j.1532-5415.2008.01935.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Schulz, K. F., Altman, D. G., and Moher, D. (2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 8:18. doi: 10.1186/1741-7015-8-18

PubMed Abstract | CrossRef Full Text | Google Scholar

Suresh, K. (2011). An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J. Hum. Reprod. Sci. 4, 8–11. doi: 10.4103/0974-1208.82352

CrossRef Full Text | Google Scholar

Tajudeen, F. P., Bahar, N., Tan, M. P., Peer Mustafa, M. B., Saedon, N. I., and Jesudass, J. (2022). Understanding user requirements for a senior-friendly mobile health application. Geriatr. 7, 1–21. doi: 10.3390/geriatrics7050110

PubMed Abstract | CrossRef Full Text | Google Scholar

Vainieri, M., Vandelli, A., Benvenuti, S. C., and Bertarelli, G. (2023). Tracking the digital health gap in elderly: a study in Italian remote areas. Health Policy. 133:104842. doi: 10.1016/j.healthpol.2023.104842

PubMed Abstract | CrossRef Full Text | Google Scholar

Valokivi, H., Carlo, S., Kvist, E., and Outila, M. (2023). Digital ageing in Europe: a comparative analysis of Italian, Finnish and Swedish national policies on eHealth. Ageing Soc. 43, 835–856. doi: 10.1017/S0144686X21000945

CrossRef Full Text | Google Scholar

Van der Linde, R. M., Stephan, B. C. M., Dening, T., and Brayne, C. (2014). Instruments to measure behavioural and psychological symptoms of dementia. Int. J. Methods Psychiatr. Res. 23, 69–98. doi: 10.1002/mpr.1414

CrossRef Full Text | Google Scholar